临床儿科杂志 ›› 2021, Vol. 39 ›› Issue (12): 938-.doi: 10.3969/j.issn.1000-3606.2021.12.013

• 综合报道 • 上一篇    下一篇

儿童抗N- 甲基-D- 天冬氨酸受体脑炎合并横纹肌溶解症4 例分析

侯池, 李小晶, 田杨, 曾意茹, 朱海霞, 张雅妮, 郑可鲁, 廖寅婷, 彭炳蔚, 梁惠慈, 高媛媛, 陈文雄   

  1. 广州市妇女儿童医疗中心(广东广州 510120)
  • 发布日期:2021-12-22
  • 通讯作者: 广州市卫生和计划生育科技项目(No.20181A011038)
  • 基金资助:
    陈文雄 电子信箱:chenwenxiong@gwcmc.org

Anti-N-methyl-D-aspartate-receptor encephalitis with rhabdomyolysis in children

HOU Chi, LI Xiaojing, TIAN Yang, ZENG Yiru, ZHU Haixia, ZHANG Yani, ZHENG Kelu, LIAO Yinting, PENG Bingwei, LIANG Huici, GAO Yuanyuan, CHEN Wenxiong   

  1. Guangzhou Women and Children's Medical Center, Guangzhou 510120 , Guangdong, China
  • Online:2021-12-22

摘要: 目的 分析儿童抗N-甲基-D-天冬氨酸受体(anti-N-methyl-D-aspartate-receptor, NMDAR)脑炎合并横纹 肌溶解症(rhabdomyolysis, RM)的临床特点及预后。方法 回顾分析4例抗NMDAR脑炎合并RM患儿的临床资料。结 果 患儿平均起病年龄为(9.3±4.3)岁,男3例、女1例,出现首发症状至确诊为抗NMDAR脑炎的中位时间为14(10~20)天, 出现首发症状至发展为RM的中位时间为29(22 ~ 40)天。RM的诱因包括感染及癫痫持续状态(3例),持续不自主运动(1 例)。4例患儿中1例患儿接受糖皮质激素、静脉输注人免疫球蛋白及水化碱化治疗后恢复好;其余3例合并感染及癫痫持 续状态者对上述治疗反应差,接受血浆置换及持续血液滤过治疗,1例死于脓毒性休克,另外2例最终接受利妥昔单抗治疗, 1例有效,1例遗留严重神经系统后遗症。结论 儿童抗NMDAR脑炎可合并RM,危重患者可能对一线免疫治疗及水化碱 化治疗反应不佳,应尽早启动血液净化治疗。

关键词: 抗N-甲基-D-天冬氨酸受体脑炎; 横纹肌溶解症; 儿童

Abstract: To explore the clinical features and prognosis of children with anti-N-methyl-D-aspartatereceptor (NMDAR) encephalitis complicated with rhabdomyolysis (RM). Methods The clinical data of 4 children with anti-NMDAR encephalitis complicated with RM were retrospectively analyzed. Results There were 3 boys and 1 girl with an average onset age of ( 9 . 3 ±4 . 3 ) years. The median time between onset symptom and diagnosis of anti-NMDAR encephalitis was 14 ( 10 - 20 ) days, and the median time between onset symptom and development of RM was 29 ( 22 - 40 ) days. The causes of RM included infection and status epilepticus ( 3 cases), and persistent involuntary movement ( 1 case). One patient recovered well after receiving steroid and intravenous immunoglobulin treatment and hydration and alkalization therapy. The other 3 patients with complicated infection and status epilepticus had poor response to the treatment and received plasma exchange and continuous hemofiltration. One died of septic shock, and 2 received rituximab treatment. One recovered well, while the other one had severe neurological sequelae. Conclusion Children with anti-NMDAR encephalitis can be complicated with RM. Patients in critical condition may have poor response to first-line immunotherapy and hydration and alkalization therapy, and blood purification therapy should be initiated in time.

Key words: anti-N-methyl-D-aspartate-receptor encephalitis; rhabdomyolysis; child